BR9810364A - Método para produção de tiazofurin e outros nucleosìdios-c - Google Patents

Método para produção de tiazofurin e outros nucleosìdios-c

Info

Publication number
BR9810364A
BR9810364A BR9810364-4A BR9810364A BR9810364A BR 9810364 A BR9810364 A BR 9810364A BR 9810364 A BR9810364 A BR 9810364A BR 9810364 A BR9810364 A BR 9810364A
Authority
BR
Brazil
Prior art keywords
sugar
condensed
class
thiazofurin
nucleosides
Prior art date
Application number
BR9810364-4A
Other languages
English (en)
Inventor
Kandasamy Ramasamy
Rajanikanth Bandari
Devron Averett
Original Assignee
Icn Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icn Pharmaceuticals filed Critical Icn Pharmaceuticals
Publication of BR9810364A publication Critical patent/BR9810364A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/24—Heterocyclic radicals containing oxygen or sulfur as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Patente de Invenção: <B>"MéTODO PARA PRODUçãO DE TIAZOFURIN E OUTROS NUCLEOSìDIOS-C"<D> Os nucleosídios-C são sintetizados por um método em que um açúcar é derivado em uma única etapa para proporcionar um heterociclo na posição C1, sendo depois o heterociclo aromatizado em uma outra única etapa. Em uma classe de modalidades preferidas, um ciano açúcar é convertido em tiocarboxamida e a seguir condensado para formar um anel de azol. Em uma segunda classe de modalidades preferidas, um ciano açúcar é condensado com um aminoácido para proporcionar o anel de azol. Em uma terceira classe de modalidades preferidas, um halo açúcar é condensado com um hetrocíclico previamente formado para obterse o anel de azol.
BR9810364-4A 1997-06-30 1998-06-25 Método para produção de tiazofurin e outros nucleosìdios-c BR9810364A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5119197P 1997-06-30 1997-06-30
PCT/US1998/013367 WO1999000399A1 (en) 1997-06-30 1998-06-25 Method of producing tiazofurin and other c-nucleosides

Publications (1)

Publication Number Publication Date
BR9810364A true BR9810364A (pt) 2000-09-05

Family

ID=21969870

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810364-4A BR9810364A (pt) 1997-06-30 1998-06-25 Método para produção de tiazofurin e outros nucleosìdios-c

Country Status (19)

Country Link
US (1) US6613896B1 (pt)
EP (1) EP1000075A4 (pt)
JP (1) JP2002501546A (pt)
KR (1) KR100540853B1 (pt)
CN (1) CN1261370A (pt)
AU (1) AU735601B2 (pt)
BR (1) BR9810364A (pt)
CA (1) CA2290364A1 (pt)
HU (1) HUP0002389A3 (pt)
IL (1) IL132737A0 (pt)
NO (1) NO996467L (pt)
NZ (1) NZ500831A (pt)
PL (1) PL191173B1 (pt)
RU (1) RU2185385C2 (pt)
SI (1) SI20161A (pt)
SK (1) SK172399A3 (pt)
UA (1) UA63956C2 (pt)
WO (1) WO1999000399A1 (pt)
YU (1) YU67099A (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182252A1 (en) 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
AU2015217221A1 (en) 2014-02-13 2016-08-11 Ligand Pharmaceuticals, Inc. Prodrug compounds and their uses
JP2017520545A (ja) 2014-07-02 2017-07-27 リガンド・ファーマシューティカルズ・インコーポレイテッド プロドラッグ化合物およびそれらの使用
CA3087932A1 (en) 2018-01-09 2019-07-18 Ligand Pharmaceuticals, Inc. Acetal compounds and therapeutic uses thereof
EP3773579A4 (en) 2018-03-26 2022-03-09 Clear Creek Bio, Inc. COMPOSITIONS AND METHODS FOR INHIBITING DIHYDROOROTATE DEHYDROGENASE
TWI794742B (zh) 2020-02-18 2023-03-01 美商基利科學股份有限公司 抗病毒化合物
TWI874791B (zh) 2020-02-18 2025-03-01 美商基利科學股份有限公司 抗病毒化合物
EP4106876B1 (en) 2020-02-18 2025-09-17 Gilead Sciences, Inc. Antiviral compounds
US20210308117A1 (en) 2020-03-20 2021-10-07 Clear Creek Bio, Inc. Methods of treating viral infections using inhibitors of nucleotide synthesis pathways
KR102923359B1 (ko) 2021-04-16 2026-02-05 길리애드 사이언시즈, 인코포레이티드 아미드를 사용한 카르바뉴클레오시드를 제조하는 방법
EP4387977A1 (en) 2021-08-18 2024-06-26 Gilead Sciences, Inc. Phospholipid compounds and methods of making and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451648A (en) * 1981-08-19 1984-05-29 The United States Of America As Represented By The Department Of Health And Human Services Process for the production of 2-β-D-ribofuranosylthiazole-4-carboxamide
US4531001A (en) * 1982-03-23 1985-07-23 Brigham Young University 2-β-D-ribofuranosylselenazole-4-carboxamide compounds
US4619996A (en) * 1984-07-09 1986-10-28 Warner-Lambert Company Process for preparing 2-β-D-ribofuranosylselenazole-4-carboxamide
AU5298096A (en) * 1995-02-17 1996-09-11 Icn Pharmaceuticals, Inc. Procedures for obtaining ribo-c-nucleosides
CN1268140A (zh) * 1996-10-16 2000-09-27 Icn药品公司 单环l－核苷、类似物及其应用

Also Published As

Publication number Publication date
AU8268898A (en) 1999-01-19
JP2002501546A (ja) 2002-01-15
EP1000075A4 (en) 2001-09-05
HUP0002389A3 (en) 2002-04-29
SI20161A (sl) 2000-08-31
NZ500831A (en) 2001-06-29
CA2290364A1 (en) 1999-01-07
PL191173B1 (pl) 2006-03-31
US6613896B1 (en) 2003-09-02
EP1000075A1 (en) 2000-05-17
RU2185385C2 (ru) 2002-07-20
YU67099A (sh) 2002-06-19
WO1999000399A9 (en) 1999-04-15
KR20010039514A (ko) 2001-05-15
HUP0002389A2 (hu) 2001-08-28
CN1261370A (zh) 2000-07-26
UA63956C2 (uk) 2004-02-16
AU735601B2 (en) 2001-07-12
NO996467L (no) 2000-02-23
NO996467D0 (no) 1999-12-23
PL337716A1 (en) 2000-08-28
WO1999000399A1 (en) 1999-01-07
IL132737A0 (en) 2001-03-19
KR100540853B1 (ko) 2006-01-10
SK172399A3 (en) 2000-07-11

Similar Documents

Publication Publication Date Title
BR9810364A (pt) Método para produção de tiazofurin e outros nucleosìdios-c
CO5251454A1 (es) Derivados aromaticos y heteroaromaticos de 1,5-benzodiazepin-2-onas
DE69803750D1 (de) Thiazolidinedione- und oxazolidinedione-derivate mit antidiabetischen, hypolipidämischen und anti hypertensiven eigenschaften
BR0111754A (pt) Uso de um composto, método para inibir aurora 2 quinase em um animal de sangue quente, composto, e, composição farmacêutica
PL342608A1 (en) Novel heterocyclic compounds, method of obtaining them, pharmacological compositions containing such compounds and their application in treating diabetes and its associated diseases
BR0008222A (pt) Produção de derivados de isoflavona
NO940261L (no) 5-leddete heterocykler, fremgangsmåte ved fremstilling derav og legemidler som inneholder disse forbindelser
WO2004093759A8 (en) Thermal therapy sleeve
KR880002834A (ko) α-알킬-4-아미노-3-퀴놀린메탄올 및 1-(4-아르알킬아미노-3-퀴놀리닐) 알칸온, 이의 제조방법 및 약제로서의 용도
BR0012489A (pt) Composto, composição farmacêutica, uso de um composto, e, kit para a contracepção masculina
BR0308145A (pt) Composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto
BR0308144A (pt) Composto, composição farmacêutica, uso de um composto, e, processo para a preparação de um composto
WO2004007521A3 (en) Bile acid derivatives as agonists of the farnesoid x receptor
AU2003294092A1 (en) Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics
BR9912870A (pt) Processo para sìntese de derivados de (1h) - benzo (c)quinolizina-3-onas
DE69706382D1 (de) Verfahren zur herstellung von 2,2&#39;-bipyrrolyl-pyrromethen-derivaten (prodigiosine)
BR9714066A (pt) Processo para a preparação de derivados de tiazol.
NO983860L (no) Nye triazolopuriner, fremgangsmÕte for deres fremstilling og deres anvendelse som legemidler
JP2001504396A5 (pt)
UY24886A1 (es) Tiazolidindiona
WO2001040219A3 (de) Verfahren zur herstellung von 5-(1-piperazinyl)-benzofuran-2-carboxamid durch übergansmetall-katalysierte aminierung
BR0005532A (pt) Derivados heterocìclicos substituìdos
BR0109268A (pt) Método de preparação de citalopram, composto e citaplopram
BR0207886A (pt) Ciclopropa-heterociclos como inibidores de transcriptase reversa não-nucleosìdeos
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: VALEANT PHARMACEUTICALS INTERNATIONAL (US)

Free format text: ALTERADO DE: ICN PHARMACEUTICALS, INC.

B25A Requested transfer of rights approved

Owner name: RIBAPHARM INC. (US)

Free format text: TRANSFERIDO DE: VALEANT PHARMACEUTICALS INTERNATIONAL

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DA(S) 9A E 10A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 1986 DE 27/03/2009.